| Name | Title | Contact Details |
|---|
Michiana Behavioral Health Center is a Plymouth, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Celestiallabs is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orion Health is a global, award-winning provider of health information technology, advancing population health and precision medicine solutions for the delivery of care across the entire health ecosystem. Founded in 1993, Orion Health`s focus for 28 years has been on delivering software, services and support for healthcare organisations that empower clinicians and caregivers with the right information to deliver the best possible care. We specialise in open technology systems that seamlessly integrate all forms of health and personal data across the entire health community and present that data back to users in real-time to provide optimum patient care. We believe that software needs to do more than serve up data; it needs to provide insights in real-time to the people who need it when they need it. We provide a smart suite of solutions that enable clinicians to extract meaningful insights and make more accurate decisions about patient care. Delivering patient-centred healthcare and quality health outcomes that help patients live a healthier life. Orion Health employs 500+ people in 20 offices across 13 countries. Our technology is used by hundreds of thousands of clinicians worldwide to manage the health care of more than 100 million patients. With the most widely deployed population health management platform globally; more than 55 large-scale (regional and country-wide) solutions successfully deployed in over 15 countries, we provide the world`s number one health information platform.
Arbor House Assisted Living is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.